SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

An Wen Chan, Jennifer M. Tetzlaff, Peter C. Gøtzsche, Douglas G. Altman, Howard Mann, Jesse A. Berlin, Kay Dickersin, Asbjørn Hróbjartsson, Kenneth F. Schulz, Wendy R. Parulekar, Karmela Krleza-Jeric, Andreas Laupacis, David Moher

Research output: Contribution to journalArticle

Abstract

High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders.

Original languageEnglish (US)
Article numbere7586
JournalBMJ (Online)
Volume346
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Clinical Protocols
Checklist
Clinical Trials
Documentation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chan, A. W., Tetzlaff, J. M., Gøtzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., ... Moher, D. (2013). SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (Online), 346, [e7586]. https://doi.org/10.1136/bmj.e7586

SPIRIT 2013 explanation and elaboration : guidance for protocols of clinical trials. / Chan, An Wen; Tetzlaff, Jennifer M.; Gøtzsche, Peter C.; Altman, Douglas G.; Mann, Howard; Berlin, Jesse A.; Dickersin, Kay; Hróbjartsson, Asbjørn; Schulz, Kenneth F.; Parulekar, Wendy R.; Krleza-Jeric, Karmela; Laupacis, Andreas; Moher, David.

In: BMJ (Online), Vol. 346, e7586, 2013.

Research output: Contribution to journalArticle

Chan, AW, Tetzlaff, JM, Gøtzsche, PC, Altman, DG, Mann, H, Berlin, JA, Dickersin, K, Hróbjartsson, A, Schulz, KF, Parulekar, WR, Krleza-Jeric, K, Laupacis, A & Moher, D 2013, 'SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.', BMJ (Online), vol. 346, e7586. https://doi.org/10.1136/bmj.e7586
Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (Online). 2013;346. e7586. https://doi.org/10.1136/bmj.e7586
Chan, An Wen ; Tetzlaff, Jennifer M. ; Gøtzsche, Peter C. ; Altman, Douglas G. ; Mann, Howard ; Berlin, Jesse A. ; Dickersin, Kay ; Hróbjartsson, Asbjørn ; Schulz, Kenneth F. ; Parulekar, Wendy R. ; Krleza-Jeric, Karmela ; Laupacis, Andreas ; Moher, David. / SPIRIT 2013 explanation and elaboration : guidance for protocols of clinical trials. In: BMJ (Online). 2013 ; Vol. 346.
@article{96d4cb517edc4146bc6919f410fedd9b,
title = "SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.",
abstract = "High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders.",
author = "Chan, {An Wen} and Tetzlaff, {Jennifer M.} and G{\o}tzsche, {Peter C.} and Altman, {Douglas G.} and Howard Mann and Berlin, {Jesse A.} and Kay Dickersin and Asbj{\o}rn Hr{\'o}bjartsson and Schulz, {Kenneth F.} and Parulekar, {Wendy R.} and Karmela Krleza-Jeric and Andreas Laupacis and David Moher",
year = "2013",
doi = "10.1136/bmj.e7586",
language = "English (US)",
volume = "346",
journal = "British Medical Journal",
issn = "0959-8146",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - SPIRIT 2013 explanation and elaboration

T2 - guidance for protocols of clinical trials.

AU - Chan, An Wen

AU - Tetzlaff, Jennifer M.

AU - Gøtzsche, Peter C.

AU - Altman, Douglas G.

AU - Mann, Howard

AU - Berlin, Jesse A.

AU - Dickersin, Kay

AU - Hróbjartsson, Asbjørn

AU - Schulz, Kenneth F.

AU - Parulekar, Wendy R.

AU - Krleza-Jeric, Karmela

AU - Laupacis, Andreas

AU - Moher, David

PY - 2013

Y1 - 2013

N2 - High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders.

AB - High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders.

UR - http://www.scopus.com/inward/record.url?scp=84872080748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872080748&partnerID=8YFLogxK

U2 - 10.1136/bmj.e7586

DO - 10.1136/bmj.e7586

M3 - Article

C2 - 23303884

AN - SCOPUS:84872080748

VL - 346

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8146

M1 - e7586

ER -